Press release
Creative Diagnostics Announces Cutting-Edge DNA/RNA Methylation Antibodies for Cancer Research
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the availability of a comprehensive range of highly validated DNA/RNA methylation antibodies [https://www.creative-diagnostics.com/dna-rna-methylation-antibodies.htm] for researchers studying the critical role of methylation in cancer development and progression. These antibodies are designed to facilitate groundbreaking research in epigenetics and cancer diagnostics.
To date, at least 17 and 160 chemical modifications have been identified in DNA and RNA, respectively. With more than 70 of the known RNA modifications containing methyl groups, the importance of methylation modifications cannot be overstated. Analysis of nucleic acid methylation and its functional effects is of critical importance to epigenetic researchers. In addition, methylation profiles of the epigenome can be used for disease identification, research and therapeutic development.
The detection of methylation in DNA and RNA is particularly important for the diagnosis and treatment of various tumor diseases. CpG island DNA methylation plays a key role in X chromosome inactivation, imprinting, and cancer, and is rare in normal cells and increases with age. There is evidence for hypermethylation of CpG island promoters of tumor suppressor genes such as p16INK4a in melanoma, SET9 in cervical cancer, and p15INK4b in hematologic malignancies.
On the other hand, RNA methylation greatly influences tissue development, DNA damage repair, and tumorigenesis and progression by regulating RNA stability. The m6A methyltransferase METTL3 is overexpressed in gastric, colorectal, and hepatocellular carcinomas and promotes cancer cell proliferation by inhibiting the tumor suppressor SOCS2. The m5C methyltransferase NSUN2 is overexpressed in breast and colorectal malignancies.
Antibodies against nucleic acid modifications have played a critical role in epigenetics and epitranscriptomics. For example, enrichment of DNA containing 5mC by methylated DNA immunoprecipitation (MeDIP) has been widely used in epigenetics for decades. Additionally, antibody-based sequencing techniques have been widely used for transcriptome studies of a variety of RNA modifications, including m6A, m1A, m5C, and m7G.
Antibody-based methods are relatively simple, fast, and cost-effective, but rely on highly specific antibodies to recognize methylated DNA/RNA. The key to generating antibodies that effectively detect RNA modifications is antigen design and antibody validation. Creative Diagnostics now offers a number of highly validated antibodies for DNA/RNA methylation analysis, such as Rabbit Anti-5-methylcytosine (5-mC) monoclonal antibody, clone SN342, Rabbit Anti-5-methylcytosine (5-mC) monoclonal antibody, clone SN342, and Sheep Anti-5-Methylcytosine polyclonal antibody. These antibodies are rigorously validated and optimized for various immunological applications, ensuring consistent and reliable results.
The company also offers a wide selection of antibodies targeting different methylation sites, providing researchers with flexibility in their experiments. Creative Diagnostics' comprehensive portfolio of methylation antibodies are essential tools for advancing the understanding of cancer and developing novel therapeutic approaches.
Creative Diagnostics is committed to providing researchers with the products they need for epigenetics and cancer research. To learn more about these antibodies and other research tools, please visit https://www.creative-diagnostics.com/dna-rna-methylation-antibodies.htm.
About Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. In addition to providing contract R&D and biologic manufacturing services for diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market, the company aims to continue to act as a trusted source for all researchers' assay development and manufacturing needs.
Media Contact
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=creative-diagnostics-announces-cuttingedge-dnarna-methylation-antibodies-for-cancer-research]
State: New York
Country: United States
Website: https://www.creative-diagnostics.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Creative Diagnostics Announces Cutting-Edge DNA/RNA Methylation Antibodies for Cancer Research here
News-ID: 3636704 • Views: …
More Releases from ABNewswire
Sober Living New York: Supporting Recovery with Structure, Stability, and Compas …
Ultimately, Sober Living New York plays a crucial role in helping individuals achieve and maintain lasting recovery. By combining structure, compassion, and community, these homes create an environment where healing can flourish. For many, they represent a fresh start-a place to rebuild confidence, restore independence, and move forward with renewed hope.
Sober Living New York is helping individuals rebuild their lives through a supportive, structured environment designed to promote long-term recovery.…
Queens Car Accident Attorney Keetick L. Sanchez Clarifies Insurance Investigatio …
Queens, NY - Queens car accident attorney Keetick L. Sanchez, of K L Sanchez Law Office, PC (https://accidentlawyer-queens.com/how-long-does-an-insurance-company-have-to-investigate-a-claim/), released a comprehensive overview of insurance claim investigation timelines and claimant rights in New York. The guidance explains how quickly insurers must acknowledge and investigate claims, the documentation policyholders should assemble, and the remedies available when carriers miss statutory or regulatory benchmarks. Designed for collision victims across Queens, the resource underscores practical…
Central New York Estate Planning Lawyer Frederick P. Davies Highlights New York …
Syracuse, NY - Frederick P. Davies of Davies Law Firm (https://davieslawfirm.com/how-new-york-medicaid-looks-at-your-homestead/) outlines how New York Medicaid evaluates the primary residence, or "homestead," and provides current figures and planning guidance for families navigating long-term care. The update explains the protections available to a homestead under New York's rules and confirms the steps a Central New York Estate Planning Lawyer can take to help families qualify for needed care while safeguarding housing…
Michigan Driver's License Restoration Lawyer Paul J. Tafelski Expands Guidance O …
Michigan - Michigan Defense Law (https://www.michigandefenselaw.com/blog/driving-on-a-suspended-license-in-michigan/) shared expanded resources led by Michigan driver's license restoration lawyer Paul J. Tafelski to assist drivers confronting suspensions and revocations under Michigan Compiled Laws, including MCL 257.904. The initiative focuses on practical, step-by-step strategies for restoring driving privileges, with particular attention to Oakland County matters, administrative hearings, and court-ordered conditions that affect eligibility and timing.
The expanded guidance clarifies critical distinctions between suspensions and revocations…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
